2022 Power 50: 44. Nicole Wagner
Nicole Wagner
Of all the bioscience companies now calling Connecticut home, Farmington-based LambdaVision may have one of the most ambitious long-term goals: development of a protein-based artificial retina that could restore meaningful vision for patients who are blind, or have lost much of their sight due to disease.
The implant is expected to be less surgically invasive than competing products, and unlike electrode-based technologies, would not require external power or hardware.
At the center of the mission is LambdaVision President and CEO Nicole Wagner, who as a Ph.D. student at UConn played a critical role in the early experiments and research that formed the underpinning for the company’s work
Since taking the helm, Wagner has secured millions of dollars in funding to help accelerate research and commercialization efforts, navigated the company through the COVID-19 pandemic and even expanded R&D work into outer space, where experiments can be conducted in weightless conditions aboard the International Space Station.
Wagner has said her goal is to get the company’s artificial retina to patients as soon as possible.
Wagner currently serves on the board of the Connecticut Technology Council and New England Women in Science Executives Club, and is a member of the International Space Station National Lab User Advisory Committee.
Most Recent
Most Recent
0 Comments